MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$4,142M
Net Income
-$576M
Net Profit Margin
-13.91%
EPS
-$0.49
Unit: Million (M) dollars
Revenue Breakdown
US
Europe
Other Activities
International Markets
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenues
4,142
3,982
4,704*
4,480
Cost of sales
1,989
2,011
2,035*
2,176
Gross profit
2,153
1,972
2,669*
2,304
Research and development expenses
970
222
259*
256
Selling and marketing expenses
717
696
769*
656
General and administrative expenses
317
304
366*
317
Intangible assets impairments
22
8
-18*
64
Goodwill impairment
-
-
0*
0
Other assets impairments, restructuring and other items
147
26
990*
62
Legal settlements and loss contingencies
230
72
248*
60
Other loss (income)
19
9
0*
-7
Operating income (loss)
-231
652
56*
882
Financial expenses, net
-224
-216
-242*
-237
Income (gain) before income taxes
-455
437
-187*
646
Income taxes (benefit)
121
67
-659*
214
Share in (profits) losses of associated companies net
-
-1
9*
2
Net income (loss)
-575
369
481
434
Net income (gain) attributable to redeemable and non-redeemable non-controlling interests
-
-
0
1
Net income (loss) attributable to teva
-576
369
481
433
Basic EPS
-0.49
0.32
0.419
0.38
Diluted EPS
-0.49
0.31
0.412
0.37
Basic Average Shares
1,165,000,000
1,156,000,000
1,148,000,000
1,147,000,000
Diluted Average Shares
1,165,000,000
1,179,000,000
1,168,000,000
1,164,000,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net income (loss)
attributable to teva
-$576M
(-304.26%↓ Y/Y)
Net income (loss)
-$575M
(-303.18%↓ Y/Y)
US
$1,702M
Europe
$1,263M
Other Activities
$627M
International Markets
$550M
Income (gain) before
income taxes
-$455M
Income taxes (benefit)
$121M
Net revenues
$4,142M
Operating income (loss)
-$231M
Financial expenses, net
-$224M
Gross profit
$2,153M
Other loss (income)
$19M
Cost of sales
$1,989M
Research and development
expenses
$970M
Selling and marketing
expenses
$717M
General and
administrative expenses
$317M
Legal settlements and
loss contingencies
$230M
Other assets
impairments, restructuring...
$147M
Intangible assets
impairments
$22M
Buy us a coffee
logo_teva-svg
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
logo_teva-svg
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
🚨
Price Alert:
The stock price jumped by 10.72% after the earning call.
Show more